Diabetes as a Determinant of Mortality in Cystic Fibrosis
暂无分享,去创建一个
Parinya Chamnan | A. Adler | D. Bilton | C. Haworth | P. Chamnan | Brian S.F. Shine | Charles S. Haworth | Diana Bilton | Amanda I. Adler | B. Shine
[1] S. Emerson,et al. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study , 2003, The Lancet.
[2] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[3] D. Geddes,et al. Incidence, population, and survival of cystic fibrosis in the UK, 1968–95 , 1997, Archives of disease in childhood.
[4] Parinya Chamnan,et al. Genetic Determinants and Epidemiology of Cystic Fibrosis–Related Diabetes , 2008, Diabetes Care.
[5] B. Strandvik,et al. Presence of cystic fibrosis‐related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European Epidemiologic Registry of Cystic Fibrosis , 2001, Pediatric pulmonology.
[6] Alexander K Rowe,et al. Why population attributable fractions can sum to more than one. , 2004, American journal of preventive medicine.
[7] J L Hankinson,et al. Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.
[8] M. Rosenfeld,et al. Gender gap in cystic fibrosis mortality. , 1997, American journal of epidemiology.
[9] A. Stolfi,et al. Insulin and oral agents for managing cystic fibrosis-related diabetes. , 2005, The Cochrane database of systematic reviews.
[10] R. Rowntree,et al. The Phenotypic Consequences of CFTR Mutations , 2003, Annals of human genetics.
[11] E. Sims,et al. Potential benefits of the UK Cystic Fibrosis Database. , 2004, Journal of the Royal Society of Medicine.
[12] A. Parant,et al. Cystic fibrosis mortality trends in France. , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[13] A. Moran,et al. Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality , 2009, Diabetes Care.
[14] M. Stanton,et al. Cystic fibrosis mortality and survival in the UK: 1947–2003 , 2007, European Respiratory Journal.
[15] T. Liou,et al. Predictive 5-year survivorship model of cystic fibrosis. , 2001, American journal of epidemiology.
[16] H. Siljander,et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial , 2008, The Lancet.
[17] C. Goss,et al. CFTR genotype as a predictor of prognosis in cystic fibrosis. , 2006, Chest.
[18] C. Weinberg,et al. Use and misuse of population attributable fractions. , 1998, American journal of public health.
[19] J. Harvey,et al. Estimation of the prevalence of diagnosed diabetes from primary care and secondary care source data: comparison of record linkage with capture-recapture analysis , 2002, Journal of epidemiology and community health.
[20] G. Velho,et al. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. , 2008, The Journal of pediatrics.
[21] J. Pilewski,et al. Insulin Therapy to Improve BMI in Cystic Fibrosis–Related Diabetes Without Fasting Hyperglycemia , 2009, Diabetes Care.